Figure 1: Median Percentage Reduction From Baseline in 28-Day Frequency of FIAS and

Figure 1 % reduction from baseline

Median Percentage Reduction From Baseline in 28-Day Frequency of FIAS and TCS by Time Point, Patients With FIAS and/or TCS at Baseline

Format

PNG

Source

Zynerba Pharmaceuticals, Inc.

Downloads